Thalys Medical Technology Group (SHSE:603716) Cyclically Adjusted FCF per Share: ¥-0.45 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603716 Thalys Medical Technology Group Corp SHSE:603716
41 GF Score
Price ¥15.84
GF Value ¥4.65
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Thalys Medical Technology Group Cyclically Adjusted FCF per Share?

Thalys Medical Technology Group SHSE:603716 -8.44% 41 Cyclically Adjusted FCF per Share is ¥-0.45 as of Mar. 2026. GuruFocus rates SHSE:603716 with a GF Score™ of 41/100 and a GF Value™ of ¥4.65 (Significantly Overvalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Thalys Medical Technology Group's adjusted free cash flow per share for the three months ended in Mar. 2026 was ¥-0.069. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥-0.45 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-23), Thalys Medical Technology Group's current stock price is ¥15.84. Thalys Medical Technology Group's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ¥-0.45. Thalys Medical Technology Group's Cyclically Adjusted Price-to-FCF of today is .


Thalys Medical Technology Group  (SHSE:603716) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Thalys Medical Technology Group Cyclically Adjusted FCF per Share Related Terms


Thalys Medical Technology Group Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Thalys Medical Technology Group's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thalys Medical Technology Group Cyclically Adjusted FCF per Share Chart

Thalys Medical Technology Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.48 -0.46

Thalys Medical Technology Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.50 -0.50 -0.47 -0.46 -0.45

SHSE:603716 vs TMO, DHR, IDXX: Cyclically Adjusted FCF per Share Comparison

For the Diagnostics & Research subindustry, Thalys Medical Technology Group's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thalys Medical Technology Group Cyclically Adjusted Price-to-FCF vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thalys Medical Technology Group's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Thalys Medical Technology Group's Cyclically Adjusted Price-to-FCF falls into.


SHSE:603716
41GF Score
Thalys Medical Technology Group Corp SHSE:603716
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thalys Medical Technology Group Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Thalys Medical Technology Group's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.069/116.3033*116.3033
=-0.069

Current CPI (Mar. 2026) = 116.3033.

Thalys Medical Technology Group Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.064 101.400 -0.073
201609 -0.384 102.400 -0.436
201612 -0.012 102.600 -0.014
201703 -0.166 103.200 -0.187
201706 -0.447 103.100 -0.504
201709 -0.046 104.100 -0.051
201712 -0.360 104.500 -0.401
201803 -0.488 105.300 -0.539
201806 -0.415 104.900 -0.460
201809 -0.245 106.600 -0.267
201812 0.020 106.500 0.022
201903 -0.539 107.700 -0.582
201906 -0.085 107.700 -0.092
201909 0.020 109.800 0.021
201912 0.570 111.200 0.596
202003 -0.453 112.300 -0.469
202006 -0.423 110.400 -0.446
202009 -0.538 111.700 -0.560
202012 0.678 111.500 0.707
202103 -0.138 112.662 -0.142
202106 -0.905 111.769 -0.942
202109 -0.526 112.215 -0.545
202112 0.394 113.108 0.405
202203 -0.585 114.335 -0.595
202206 0.108 114.558 0.110
202209 0.712 115.339 0.718
202212 -0.510 115.116 -0.515
202303 0.162 115.116 0.164
202306 0.467 114.558 0.474
202309 -0.100 115.339 -0.101
202312 0.028 114.781 0.028
202403 -0.196 115.227 -0.198
202406 -0.072 114.781 -0.073
202409 0.203 115.785 0.204
202412 0.535 114.893 0.542
202503 -0.253 115.116 -0.256
202506 -0.170 114.907 -0.172
202509 0.255 115.471 0.257
202512 -0.067 115.832 -0.067
202603 -0.069 116.303 -0.069

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥-0.45 mean?
Thalys Medical Technology Group (SHSE:603716) has a Cyclically Adjusted FCF per Share of ¥-0.45 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Thalys Medical Technology Group and its competitors.
Is Thalys Medical Technology Group's Cyclically Adjusted FCF per Share too high?
Thalys Medical Technology Group's current Cyclically Adjusted FCF per Share is ¥-0.45. Overall, Thalys Medical Technology Group has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Thalys Medical Technology Group's Cyclically Adjusted FCF per Share compare to TMO and DHR?
Thalys Medical Technology Group's Cyclically Adjusted FCF per Share of ¥-0.45 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted FCF per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Thalys Medical Technology Group and its competitors. Thalys Medical Technology Group's current Cyclically Adjusted FCF per Share is ¥-0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thalys Medical Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Thalys Medical Technology Group (SHSE:603716) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥4.65, compared to a current price of ¥15.84 — trading 240.6% above its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥-0.45. Thalys Medical Technology Group's overall GF Score™ is 41/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Thalys Medical Technology Group (SHSE:603716), the current Cyclically Adjusted FCF per Share is ¥-0.45 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Thalys Medical Technology Group (SHSE:603716) Overvalued in 2026?

Based on GuruFocus' analysis, Thalys Medical Technology Group stock appears to be overvalued. The current stock price of ¥15.84 is trading 240.6% above its estimated GF Value™ of ¥4.65. GuruFocus considers Thalys Medical Technology Group to be Significantly Overvalued.

Key valuation signals for SHSE:603716:

  • Cyclically Adjusted FCF per Share: ¥-0.45
  • GF Value™: ¥4.65 vs. price of ¥15.84 (240.6% above fair value)
  • GF Score™: 41/100 with 3 warning signs

No single metric tells the full story. See the SHSE:603716 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Thalys Medical Technology Group Business Description

Address 1310 Jinshan Avenue, Dongxihu District, Hubei Province, Wuhan, CHN, 430040
Thalys Medical Technology Group Corp is engaged in intensive sales business, pure sales, and research and development, production and sales of independent in vitro diagnostic products.
41GF Score

Get the complete analysis for SHSE:603716

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.84
Price
¥4.65
GF Value